The value of some genetic factors for prediction of chronic hepatitis C antiviral treatment effectiveness

The value of some genetic factors for prediction of chronic hepatitis C antiviral treatment effectiveness

Aim: To determine the value of gene polymorphisms of interleukin-28B (IL28B), RNase L, HLA DRB1*1101 and HLADQB1*03 alleles as predictors of antiviral treatment efficacy in patients with chronic hepatitis C (CHC).Material and methods. A total of 156 in-patients with chronic hepatitis C (65.4% men, 6...

Full description

Bibliographic Details
Main Author:	V. M. Mitsura
Format:	Article
Language:	Russian
Published:	Journal Infectology 2014-09-01
Series:	Журнал инфектологии
Subjects:	полиморфизм гена ил-28b рнка- за l hla-drb111 hla-dqb103 хронический гепатит с интерферонотерапия
Online Access:	https://journal.niidi.ru/jofin/article/view/237

Similar Items

Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)
by: I. Yu. Pirogova, et al.
Published: (2018-08-01)

Clinical Relevance of HLA-DRB1 and -DQB1 Alleles in Iranian Systemic Lupus Erythematosus Patients
by: Ashkan Rasouli-Saravani, et al.
Published: (2021-02-01)

Frequency determination of HLA-DRB1 and HLA-DQB1 alleles in children with primary vesicoureteral reflux
by: Mohammadreza Bazrafshani, et al.
Published: (2014-12-01)

Investigation The Role of Gender on The HLA-DRB1and -DQB1 Association with Type 1 Diabetes Mellitus in Iranian Patients
by: Arezou Sayad, et al.
Published: (2013-01-01)

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. A. Skvortsova, et al.
Published: (2013-05-01)

Differential Genomics Output and Susceptibility of Iranian Patients with Unilocular Hydatidose
by: Mahdi Mosayebi, et al.
Published: (2013-12-01)

Association of Human Leukocyte Antigen (HLA) class II (DRB1 and DQB1) alleles and haplotypes with Rheumatoid Arthritis in Sudanese patients
by: Adil Ahmed Ali, et al.
Published: (2023-06-01)

The Distribution of HLA-system Antigens in Children with Peptic Ulcer
by: T.V. Sorokman, et al.
Published: (2015-03-01)

HLA DRB1 and HLA DQB1 Alleles in Bulgarian Patients with Primary and Secondary Antiphospholipid Syndrome
by: Baleva M., et al.
Published: (2019-02-01)

Hematological parameters in patients with rheumatoid arthritis and gene variants HLA-DRB1*04 and HLA-DRB1*03
by: Biljana Klimenta, et al.
Published: (2020-06-01)

Association of HLA-DRB1/DQB1 Alleles and Genetic Susceptibility to Type 1 Diabetes Mellitus
by: Hiba Omer AbdelRhman Hussein, et al.
Published: (2023-08-01)

Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
by: Inga Koneczny, et al.
Published: (2021-01-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

Polymorphic variants INSIG2 rs6726538, HLA‐DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women
by: Md. Emtiaz Hasan, et al.
Published: (2021-03-01)

Investigating Associations between HLA-DR Genotype, <i>H. pylori</i> Infection, and Anti-CagA IgA Seropositivity in a Turkish Gastritis Cohort
by: Lokman Karataş, et al.
Published: (2024-03-01)

Genetic polymorphisms and effecacy of antivital therapy ofchronic viral hepatitis C
by: L I Nikolaeva, et al.
Published: (2012-06-01)

Heterogeneity of Genetic Admixture Determines SLE Susceptibility in Mexican
by: Susana Hernández-Doño, et al.
Published: (2021-08-01)

Prevalence of HLA DQB1*0602 allele in patients with migraine Prevalência do alelo HLA DQB1*0602 em pacientes com enxaqueca
by: Fernando Morgadinho Santos Coelho, et al.
Published: (2007-12-01)

Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
by: Alfred Rakissida Ouedraogo, et al.
Published: (2023-10-01)

Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso
by: Zouré Abdou Azaque, et al.
Published: (2021-10-01)

Association between HLA-DQA1, HLA-DQB1 and oral cancer
by: Sheng-Chien Tsai, et al.
Published: (2011-10-01)

CLINICAL CASE OF CO-INFECTION CAUSED BY HEPATITIS B АND D IN A CHILD OF THE FIRST YEAR OF LIFE
by: T. V. Cherednychenko, et al.
Published: (2015-08-01)

Recent advances in the treatment of chronic hepatitis B: where to start initial therapy?
by: K. V. Zhdanov
Published: (2014-09-01)

HLA-DQA1 and HLA-DQB1 Gene Polymorphism in Indonesian Children with Type I Diabetes Mellitus
by: Soetjipto, et al.
Published: (2022-01-01)

<it>HLA-DQA1</it> and <it>HLA-DQB1</it> in Celiac disease predisposition: practical implications of the HLA molecular typing
by: Megiorni Francesca, et al.
Published: (2012-10-01)

HLA class II alleles and risk for peripheral neuropathy in type 2 diabetes patients
by: Ahmad Marzban, et al.
Published: (2016-01-01)

Biochemical, serological, and genetic aspects related to gene HLA‐DQB1 and its association with type 1 diabetes mellitus (T1DM)
by: Gur Charn Singh, et al.
Published: (2020-05-01)

Association between HLA-DQB1 alleles and HAM/TSP patients in Khorasan Province
by: Amir Reza Tafreshian, et al.
Published: (2014-10-01)

Analysis of HLA-A, HLA-B and HLA-DRB1 allelic frequencies in tertiary care from Telangana and Andhra Pradesh
by: Radhika Chowdary, et al.
Published: (2014-06-01)

Correlation between HLA-DQB1 and HLA-DRB1 gene polymorphisms and caries: a systematic review and Meta-analysis
by: CHEN Yue, et al.
Published: (2021-12-01)

A study of T CD4, CD8 and B lymphocytes in narcoleptic patients Estudo dos linfócitos T CD4, CD8 e B em pacientes com narcolepsia
by: Fernando Morgadinho Santos Coelho, et al.
Published: (2007-06-01)

<i>HLA-DRB1*14:54</i> Is Associated with Pulmonary Alveolar Proteinosis: A Retrospective Real-World Audit
by: Mengqian Li, et al.
Published: (2023-10-01)

Antiviral therapy in chronic hepatitis C (G1) in Russia: cost and effectiveness
by: A. V. Rudakova, et al.
Published: (2015-04-01)

Association between HLA‐B and HLA‐DRB1 polymorphisms and systemic lupus erythematosus in Han population in China
by: Xiangyu Wang, et al.
Published: (2022-03-01)

HLA-DQB1*0301 in Bullous Pemphigoid and Pemphigus Vulgaris: A Meta-Analysis
by: Dylan Thibaut, et al.
Published: (2023-09-01)

HLA-DQA1 and HLA-DQB1 genotyping among lichen planus patients in Basrah‏ ‏province ‎
by: Nibras S. Al-Ammar
Published: (2014-06-01)

The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients
by: Arezou Sayad, et al.
Published: (2014-12-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis–From Research to Clinical Practice
by: Tomasz Wysocki, et al.
Published: (2020-05-01)